International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Nov 13, 2025, after the close
10-Q filed Nov 13, 2025, 44 days after period end · 0001193125-25-280090
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $2.37M | $2.18M | $1.97M | $1.70M |
| Net Income | $57.00K | -$125.00K | -$131.00K | -$343.00K |
| EPS Diluted | $0.00 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.02 |
| -$0.02 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
